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Pleural involvement is the most frequent thoracic complication of rheumatoid arthritis (RA), usually occurring in patients with
known RA. Typical rheumatoid pleural effusion is an exudate characterized by low pH and glucose levels and high LDH activity.
Rarely, it has features of pseudochylothorax. Other uncommon complications are pneumothorax, hydropneumothorax, em-
pyema, and bronchopleural fistula. -e case of a 51-year-old man with a spontaneous, small, and asymptomatic hydro-
pneumothorax with features of pseudochylothorax is presented. After careful clinical and laboratory evaluation, he was diagnosed
with rheumatoid arthritis, and we admitted that the pleural changes were secondary to the connective tissue disease. He started
immunosuppressive treatment and maintained stability during follow-up, without need of specific pleural treatment. We hy-
pothesized that the pleural nodule found on the chest computed tomography scan was related with the simultaneous occurrence of
pleural effusion and pneumothorax.-is is a rare presentation and complication of RA, highlighting the utility of a comprehensive
clinical and laboratory evaluation and focusing on the importance of pleural rheumatoid nodules in the pathogenesis of RA
pleural disease.
1. Introduction
Pleural disease is the most frequent intrathoracic manifes-
tation of rheumatoid arthritis (RA) and causes pleural effu-
sion in up to 20% of patients, although clinically apparent in
only 5% [1]. Pleural rheumatoid effusion is typically small,
unilateral, asymptomatic, and more commonly found in
a middle-aged man with long-standing active arthritis, sub-
cutaneous rheumatoid nodules, and high titers of rheumatoid
factor. -e effusion is an exudate with high LDH (>700U/L),
low pH (<7.2), and very low glucose (<50mg/dL in 75% of
cases). Elevated values of adenosine deaminase can be found.
In rare cases, cholesterol concentration is increased (pseu-
dochylothorax). A pleural fluid differential cell count usually
reveals predominance of neutrophils in the acute phase fol-
lowed by lymphocytes in chronicity. Its cytology may dem-
onstrate the triad of giantmultinucleated histiocytes, elongated
macrophages, and necrotic background material. Pleural
biopsy is usually not needed for diagnosis, but the presence
of classic rheumatoid nodules on the pleura is pathogno-
monic for RA [1, 2]. Most cases of pleural involvement
do not require specific treatment as they are asymptomatic
and/or resolve spontaneously or with underlying RA treat-
ment. Pneumothorax, hydropneumothorax, empyema, and
bronchopleural fistula are other uncommon RA pleural
complications, and the treatment can be challenging [3]. We
report the case of a middle-aged man presenting with pseu-
dochylothorax and spontaneous pneumothorax leading to the
diagnosis of RA.
2. Case Report
A 51-year-old man was admitted to the hospital for in-
vestigation of an asymptomatic right pleural effusion found
on routine chest radiography (Figure 1). He was a current
smoker (44 pack years) and had had tuberculosis at the age
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of 36, treated with first line drugs during one year.-ere was
no other significant past medical history, and he was not
taking any medication. His family history was irrelevant.
On physical examination, he was found to have clinical
features of a small right-sided pleural effusion. Blood tests
revealed mild chronic/inflammatory anemia (Hb 12.4 g/dL)
and leukocytosis (13.3×109/L) without neutrophilia; the
erythrocyte sedimentation rate (34mm/h) and the C-re-
active protein level (27.6mg/L) were elevated. Chest radi-
ography also showed left diaphragm retraction (Figure 1).
A computed tomography scan of the chest confirmed the
presence of a right pleural effusion with associated pleural
thickening and showed ipsilateral small basal pneumotho-
rax; a pleural nodule was noted. On the left, a slight focal
basal pleural thickening and upper lobe residual parenchymal
changes were consistent with past tuberculosis (Figure 2).
-ere was no evidence of tuberculosis reactivation, lung
consolidation, nodules or masses, emphysema, or enlarged
mediastinal lymph nodes.
-rough thoracentesis, a milky fluid was obtained, with
very low pH (7.0). Empyema was suspected, and the patient
was treated accordingly, with chest tube drainage and
intravenous broad-spectrum antibiotics. Biochemical fluid
analysis revealed an exudate (proteins 68.9 g/L; lactate
dehydrogenase (LDH) 2986U/L) with very low glucose
(<10mg/dL), high adenosine deaminase (201U/L), and
high cholesterol (205mg/dL). On microscopic examina-
tion, cholesterol crystals were observed. Gram and
Ziehl–Neelsen stains were negative. Pleural fluid cytology
was normal, and blind pleural biopsies revealed fibrosis
Figure 1: Chest radiography showing right-sided pleural effusion and left diaphragmatic retraction.
(a) (b)
(c) (d)
Figure 2: Computed tomography scan of the chest showing on the right lung: (a) hydropneumothorax, (b) basal pleural nodule, and (c) pleural
thickening; on the left lung: (a) basal pleural residual changes and (d) upper lobe residual parenchymal changes consistent with past tuberculosis.
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and marked inflammatory infiltrate without granulomas or
neoplastic tissue. -e diagnosis of pseudochylothorax was
then established.
After careful anamnesis, the patient revealed complains
of pain and swelling of multiple joints (hands, wrists, elbows,
and knees) for some years. Subcutaneous nodules were seen
on his left elbow and wrist (Figure 3), which proved to be RA
nodules after surgical excision.
Rheumatoid factor was weakly positive (31.3UI/mL),
and anti-cyclic citrullinated peptide antibody was highly
positive (>250UA/mL). According to 2010 American Col-
lege of Rheumatology/European League Against Rheuma-
tism (ACR-EULAR) classification criteria [4], the patient
was diagnosed with RA.
-e antibiotics were stopped after seven days, the chest
tube was removed, and the patient was discharged home.
Immunosuppressive treatment was initiated at rheumatol-
ogy outpatient clinic, with improvement of the articular
symptoms. Two years after the diagnosis, the patient has no
respiratory symptoms, pneumothorax has not recurred, and
pleural effusion is stable without any additional therapy
directed at the pleural space.
3. Discussion
To the best of our knowledge, this is the second reported case
of the simultaneous occurrence of pseudochylothorax and
pneumothorax in a patient presenting with rheumatoid
arthritis [5]. Other cases of hydropneumothorax have been
documented in RA patients, but none with accompanying
pseudochylothorax [6–11].
In our case, pleural fluid biochemical features and the
patient’s past of tuberculosis and smoking habits raised
suspicion for tuberculosis relapse or cancer. On the other
hand, we decided to maintain treatment for empyema until
pleural infection was ruled out. -e negative pleural fluid
cultures and unspecific pleural biopsies in the absence of
classic clinical and radiological picture of tuberculosis,
cancer or empyema, were helpful. Rheumatoid nodules were
not found on blind pleural biopsies, but thoracoscopy was
not performed as the diagnosis of RA was established and
the pleural effusion resolved. -e diagnosis was based on the
finding of pseudochylothorax in a patient with articular
complaints, positive rheumatoid factor, positive anti-cyclic
citrullinated peptide antibody, and pathology-proven sub-
cutaneous RA nodules. -e chest computed tomography
scan showed a pleural nodule we speculate to be a rheu-
matoid nodule, probably explaining the simultaneous oc-
currence of pseudochylothorax (in the absence of significant
pleural thickening) and pneumothorax.
Pseudochylothorax (chyliform or cholesterol pleurisy) is
a rare pleural effusion with milky appearance because of its
high lipid content. Typically, the pleural fluid cholesterol
level is greater than 200mg/dL, the triglyceride level is below
110mg/dL, the cholesterol/triglycerides ratio is >1, and
cholesterol crystals are present [12, 13]. -e last two pa-
rameters seem to be the most sensitive to establish the di-
agnosis [13]. Tuberculosis is by far its most frequent cause,
followed by RA. A recent systematic review revealed that
they account together for 88.5% of all cases of pseudochy-
lothorax (tuberculosis 50.6% and RA 37.9%). Less than 40
cases of RA-associated pseudochylothorax have been re-
ported in the literature [13].
-e reason why pseudochylothorax occurs in RA re-
mains unknown. It was thought that it could only develop in
patients with chronic pleural effusions (usually of five years’
duration or longer) and thickened or calcified pleura [14]. In
these circumstances, cholesterol is filtrated into the pleural
space during inflammation, and it also originates from the
lysis of erythrocytes and neutrophils, being trapped within
the pleural space as it cannot be reabsorbed. However, in
recent years, some cases have been reported with minimal or
without pleural thickening, putting it out as a key factor of
pseudochylothorax etiopathogenesis [15–17].
Some authors suggested the hypothesis that rheumatoid
pleural effusions develop as an inflammatory response to the
presence of rheumatoid nodules [10, 11]. -ose nodules are
infrequently seen in RA population (1%) and, like pleural
effusions, are usually associated with long-standing seropos-
itive RA, male sex, and subcutaneous rheumatoid nodules.
-e nodules are subpleural or pleural in distribution, vary in
size, and are mostly asymptomatic.-e cavitation and rupture
of these lesions into the pleura space may occur due to their
large amounts of proteolytic enzymes. -e result can be a
pneumothorax, hydropneumothorax, empyema, or bron-
chopleural fistula [2].
-is case illustrates a very unusual presentation and
complication of rheumatoid pleural disease. It suggests that
when a pleural effusion is detected and has pseudochylothorax
features (even in the absence of marked pleural thickening),
the diagnosis of RA should be considered, particularly in
patients with articular complaints. -e simultaneous occur-
rence of pneumothorax highlights the importance of rheu-
matoid nodules in the pathogenesis of RA pleural disease.
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Figure 3: Subcutaneous rheumatoid arthritis nodule.
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quilotórax sin engrosamiento pleural associado a artritis
reumatoide,” Archivos de Bronconeumoloǵıa, vol. 52, no. 10,
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